INFOSCUM.COM
Cash-rich Pfizer to pay $11.6 billion for Biohaven in biggest deal since 2016 - CNBC
Published Date:
5/10/2022
Source:
news.google.com
Cash-rich Pfizer to pay $11.6 billion for Biohaven in biggest deal since 2016
CNBC
BHVN Stock Rockets: Pfizer Snaps Up Biohaven For Nearly $12 Billion
Investor's Business Daily
Pfizer buys migraine partner Biohaven for $11.6 B, betting on CGRP drugs in grand return to neuroscience
FiercePharma
Pfizer deal will help expand reach of migraine pill Nurtec, Biohaven CEO says
CNBC
Biohaven CEO discusses Pfizer's purchase of the company
CNBC Television
View Full Coverage on Google News
Read the Full Story Here
InfoScum.com